This content is machine translated 9th Zurich Hypertension Day Relaxed blood pressure targets for high-risk patients The 9th Zurich Hypertension Day focused on the changes to the European Hypertension Guidelines and the treatment of important concomitant or secondary diseases such as atrial fibrillation.
View Post 6 min This content is machine translated Chronic heart failure and stroke prevention in VHF. Optimized treatment regimens and new therapeutic options The December lecture series in Zurich featured a presentation by PD Georg Noll, MD, on the treatment of chronic heart failure, in which he shared his practical clinical experience. The…
View Post 7 min This content is machine translated 4th Bern Heart Valve Symposium New transfemoral TAVI systems and the Swiss TAVI Registry The new transfemoral TAVI systems, either in development or already certified, address potential vulnerabilities and limitations, such as paravalvular insufficiency or risk of vascular complication. This article, based on a…
View Post 4 min This content is machine translated Diabetes mellitus Type 2 diabetes – Targeting the inflammation At the advanced training day “Pro and Contra in Endocrinology” in Biel, Prof. Marc Donath, MD, Chief of Endocrinology, Diabetology and Metabolism at the University Hospital Basel, spoke on the…
View Post 3 min This content is machine translated Tumor patients A significantly increased risk of severe pulmonary embolism At the 24th Physicians’ Continuing Education Course in Clinical Oncology in St. Gallen was about the risk for venous thrombosis and pulmonary embolism in patients with malignant tumors. Not only…
View Post 4 min This content is machine translated Hepatocellular carcinoma What comes after sorafenib? At the ASCO-GI in San Francisco, hepatocellular carcinoma was one of the focal points. How can therapy be optimized and what are the options for patients who are progressive during…
View Post 4 min This content is machine translated Helicobacter pylori Eradication for the prevention of gastric cancer? At ASCO-GI in San Francisco, David Graham, MD, of Baylor College of Medicine, gave a presentation on the relationship between Helicobacter pylori and gastric cancer, emphasizing the importance of preventive…
View Post 6 min This content is machine translated ASH Congress in New Orleans What were the highlights? At the end of 2013, the 55th annual congress of the “American Society of Hematology” took place. Over 22,000 participants came to New Orleans, or “The Big Easy” as the…
View Post 4 min This content is machine translated Non-Hodgkin's Lymphoma Bortezomib in previously untreated multiple myeloma. A subanalysis of the VISTA trial was presented at the ASH Congress in New Orleans, showing that a higher cumulative dose of bortezomib resulted in a better outcome in patients…
View Post 6 min This content is machine translated Progressive multiple sclerosis The next challenge is already waiting For the 16th time, the traditional State-of-the-Art Symposium of the Swiss Multiple Sclerosis Society took place in Lucerne in January 2014. This time, the presentations by national and international MS…
View Post 4 min This content is machine translated Gastric Cancer Targeted therapies in HER2-positive tumors. To what extent does the biological understanding of the disease help define the therapy? This question was discussed at the ASCO-GI in San Francisco with regard to potential treatment options…
